News

In most cases, the disease is far advanced when it is diagnosed – despite first warning signs years before. This is what HIH scientist Dr. Kathrin…

This week is Brain Awareness Week. The Hertie Foundation spoke with a family in which two sons suffer from the rare neurological hereditary disease…

Tübingen researchers develop a three-dimensional brain tissue model to study environmental influences on embyronal brain development in the Petri…

Prof. Dr. Matthis Synofzik develops tailored therapies for certain rare gene mutations. The German TV channel ZDF has now reported on the treatment of…

In an interview with the Hertie Foundation on the occasion of the International Day of Women and Girls in Science on February 11, Dr.…

Aim of the Hertie Institute for Artificial Intelligence in Brain Health (Hertie AI) is to use advances in artificial intelligence for patients with…

After a successful review, the Hertie Foundation extends the funding program "Hertie Network of Excellence in Clinical Neuroscience” for another three…

PD Dr. Kathrin Brockmann leads the research group “Clinical Parkinson Research” at the HIH. In an interview with the Hertie Foundation, she explains…

An international team with significant participation of Tübingen researchers led by Professor Dr. Matthis Synofzik has uncovered what is currently…

More than 8000 people in Germany are diagnosed with a primary brain tumor every year. In children, brain tumors are even the second most common…